GreenShoot Capital recently announced it is partnering with Medical Home Development Group, LLC to invest in a multi-state expansion of the Opioid Collaborative. Currently operating in six states and the District of Columbia, the Opioid Collaborative is a leading provider of primary and specialty care solutions that address the opioid epidemic.
With this partnership, the Opioid Collaborative will expand to three additional states over the next 12 months, providing access to care for thousands of consumers who are affected by the nation’s opioid crisis. That care includes services and clinical solutions such as evidence-based medication-assisted treatment (MAT), chronic care, mental health and addiction disorder therapy, management solutions, and others.
GreenShoot Capital is dedicated to providing liquidity, growth capital, and flexible long-term management solutions to entrepreneurial partners in the southeast. Medical Home Development Group (MHDG) is a physician owned Independent Physician Association (IPA) Group Practice with the expertise in consumer-centered primary care, addiction disorder medicine, care coordination, transitions to care and social work, and behavioral health support needed to employ a chronic care management model to address addiction and recovery.
This was reported by Markets Insider on August 30, 2018.
Contact Information: Greenshoot Capital Management, LLC, 1985 Riviera Drive Suite 103-190, Mount Pleasant, South Carolina 29464; (816) 582-6202; Website: www.greenshootcm.com
Contact Information: Medical Home Development Group Management Services, 4975 Lacross Road, Suite 153, North Charleston, South Carolina 29406; (202) 684-2784; Email: firstname.lastname@example.org; Website: www.mhdgroups.net